A Randomized Controlled Trial of Methylprednisolone Versus Standard of Care in Patients Undergoing Major Hepatectomy
A Randomized Controlled Trial of Methylprednisolone Versus Standard of Care in Patients Undergoing Major Hepatectomy
The purpose of this study is to test whether receiving methylprednisolone before surgery will reduce the side effects of having surgery, such as infections and longer hospital stays.
Inclusion Criteria:
Exclusion Criteria:
Known or documented adverse reactions to methylprednisolone.
Unable to receive methylprednisolone because of coexisting medical conditions.
Long-term (≥10-day course) systemic corticosteroid use, regardless of dose, if doses have been administered within 30 days of the planned date of surgery. This will not apply to steroids administered, in accordance with the standard of care, with preoperative chemotherapy. The following uses of corticosteroids are permitted: single doses, topical applications (e.g., for rash), inhaled sprays (e.g., for obstructive-airway diseases), eye drops, and local injections (e.g., intra-articular).
Significant chance (based on surgeon judgement) of being unable to successfully complete surgery because of unresectability.
Expected or highly likely to undergo concomitant major organ resection (stomach, pancreas, colon, rectum, uterus, ovaries, bladder, kidney, small bowel).
Expected or highly likely to undergo biliary tree reconstruction via creation of a biliary-enteric anastomosis.
Scheduled to undergo concurrent insertion of a hepatic artery infusion pump device.
Estimated renal dysfunction defined by any of the following: creatinine clearance
≤40 mL/min as calculated by the Cockcroft-Gault Equation, currently on hemodialysis, currently on peritoneal dialysis.
Dependence on mechanical ventilation before surgery.
Pregnant or nursing (lactating), where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive hCG laboratory test.
Known at the time of enrollment to have a bacterial infection that is expected to be present at the time of surgery or receipt of systemic antibiotic or antifungal therapy within 7 days before surgery.
Unable to provide informed consent
dangelim@MSKCC.ORG212-639-3226
kinghamP@mskcc.org212-639-5260
Chicago, Illinois 606012, United States
312-738-3732
Chicago, Illinois 60637, United States
Indianapolis, Indiana 46202, United States
Lexington, Kentucky 40536-0093, United States
St Louis, Missouri 63110, United States
Omaha, Nebraska 68198-7680, United States
New Brunswick, New Jersey 08903, United States
Commack, New York 11725, United States
Harrison, New York 10604, United States
New York, New York 10065, United States
La Crosse, Wisconsin 54601, United States
773-702-1470
317-944-0920
319-356-1727
859-257-9612
517-205-1594
507-284-2511
314-362-2538
402-559-5600
732-235-6780
212-639-3226
212-639-3226
516-734-8973
646-501-4848
212-639-3226
315-464-5540
919-613-1474
608-775-2331
608-263-0786